In line with the observed increase in tumor growth of shCav1 PC3-derived tumors we further detected an increased immunoreactivity to the universal proliferation marker proliferating cell nuclear antigen (Pcna) in these tumors (Fig. 3A). Here, PCNA is linked to neoplasm.